Effect of different vasodilators on NTPDase activity in healthy and hypertensive patients

Thrombosis Research

Volumn 124, Issue 3, 2009, Pages 268-274

  Lunkes, Daniéle Sausen ^a   Lunkes, Gilberto Inácio ^a   Ahmed, Mushtaq ^a   Morsch, André L B ^a   Zanin, Rafael Fernandes ^a   Maldonado, Paula Acosta ^a   Corrêa, Maísa ^a   Schetinger, Maria Rosa Chitolina ^a   Morsch, Vera Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Hypertension; Kinetic parameters; NTPDase; Vasodilators

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARGININE; CALCIUM ION; CAPTOPRIL; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRALAZINE; NITROPRUSSIDE SODIUM; NUCLEOSIDE TRIPHOSPHATASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROLYSIS; HYPERTENSION; KINETICS; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

ADENOSINE TRIPHOSPHATASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 67649804364     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.12.004     Document Type: Article

References (48)

1. Verbeberk W.J., Thien T., Kroon A.A., Lenders J.W.M., Montfrans G.A.V., Smit A.J., et al. Prevalence and persistence of masked hypertension in treated hypertensive patients. Am J Hypertens 20 12 (2007) 1258-1265
2. Kinzie J.D., Riley C., McFarland B., Hayes M., Boehnlein J., Leung P., et al. High prevalence rates of diabetes and hypertension among refugee psychiatric patients. J Nerv Ment Dis 196 2 (2008) 108-112
3. Lip G.Y.H. Hypertension, platelets and the endothelium. Hypertension 41 199 (2003)
4. Brydon L., Magid K., and Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun 20 (2006) 113-119
5. Dockrell M.E.C., Walter B.R., Noon J.P., Watt G.C.M., Williams B.C., and Webb D.J. Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability. Thromb Res 117 6 (2006) 615-622
6. Dockrell M.E.C., Walter B.R., Noon J.P., Watt G.C.M., Williams B.C., and Webb D.J. Platelet aggregation in young men with contrasting predisposition to high blood pressure. Am J Hypertens 12 (1999) 115-119
7. Gayle III R.B., Malliszewski C.R., Gimpel S.D., Schoenborn M.A., Caspary R.G., Richards C., et al. Inhibition of platelet unction by recombinant soluble ecto-ADPase/CD39. J Clin Invest 101 9 (1998) 1851-1859
8. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., Islam N., Pinsky D.J., Sesti C., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1 (2003) 2497-2509
9. Rex S., and Freedman J.E. Inhibition of platelet function by the endothelium. Platelets (2007) 251-279
10. Pilla C., Emanuelli T., Frasetto S.S., Battastini A.M.O., Dias R.D., and Sarkis J.J.F. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7 (1996) 225-230
11. Schetinger M.R.C., Vieira V.L.P., Morsch V.M., and Balz D. ATP and ADP hydrolysis in fish, chicken and rat synaptosomes. Comp Biochem Physiol 128 (2001) 731-741
12. Balz D., Wyse A.T.S., Morsch V.M., Silva A.C., Vieira V.L., Morsch A.L.B., et al. In vitro effects of L-arginine and guanidine compounds on NTPDase1 and 5-nucleotidase activities from rat brain synaptosomes. Int J Dev Neurosci 21 (2003) 75-82
13. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2 (2006) 409-430
14. Frassetto S.S., Dias R.D., and Sarkis J.J.F. Characterization of an ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 129 (1993) 47-55
15. Lunkes G.I., Lunkes D., Stefanello F., Morsch A., Morsch V.M., Mazzanti C.M., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109 (2003) 189-194
16. El-Omar M.M., Islam N., Broekman M.J., Drosopoulos J.H.F., Roa D.C., Lorin J.D., et al. The ratio of ADP-to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease. Thromb Res 116 3 (2005) 199-206
17. Atkinson B., Dwyer K., Enjyoji K., and Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic target. Blood Cells Mol Dis 36 2 (2006) 217-222
18. Leal C.A.M., Schetinger M.R.C., Leal D.B.R., Bauchspiess K., Schrekker C.M.L., Maldonado P.A., et al. NTPDase and 5′-nucleotidase activities in platelets of human pregnant with a normal or high risk fro thrombosis. Mol Cell Biochem 304 1-2 (2007) 325-330
19. Duarte M.M., Loro V.L., Rocha J.B., Leal D.B., Bem A.F., Dorneles A., et al. Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes. FEBS J 274 9 (2007) 2707-2714
20. Blann A.D., Nadar S., and Lip G.Y.H. Pharmacological modulation of platelet function in hypertension. Hypertension 42 1 (2003)
21. Crimi E., et al. Microcirculation and oxidative stress. Free Radic Res 41 12 (2007) 1364-1375
22. Fürstenau C.R., Spier A.P., Rücker B., Berti S.L., Battastini A.M.O., and Sarkis J.J.F. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes. Thromb Res 120 (2007) 877-884
23. Batlouni M., and Ramires J.A.F. Farmacologia e Terapêutica Cardiovascular (1999), Atheneu, São Paulo
24. Preli R.B., Klein K.P., and Herrington. Vascular effects of dietary L-arginine supplementation. Atherosclerosis 162 (2002) 1-15
25. Iyu D., Atucha N.M., Martinez-Prieto C., Ortiz C., and Garcia-Estan J. Altered calcium signaling in platelets from nitric oxide-deficient hypertensive. Cell Commun Signal 2 1 (2004)
26. Afonssi G., Russo I., Massucco P., Mattiello L., Balbo A., Cavalot F., et al. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. Thromb Res 102 (2001) 319-330
27. Morgan R.O., and Newby A.C. Nitroprusside differentially inhibits ADP -stimulated calcium influx and mobilization in human platelets. Biochem J 258 (1989) 447-454
28. Gudmundsdóttir I.J., McRobbie S.J., Robinson S.D., Newby D.E., and Megson I.L. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation. Biochem Biophys Res Commun 337 1 (2005) 382-385
29. 2+-activated K+ channels. Eur J Pharmacol 361 (1998) 43-49
30. Robinson M.A., Welsh D.C., Bickel D.J., Lynch J.J., and Lyle E.A. Differential effects of sodium nitroprusside and hydralazine in rat model of topical FeCl3-induced carotid artery thrombosis. Thromb Res 111 (2003) 59-64
31. Crane M.S., Rossi A.G., and Megson I.L. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations. Br J Pharmacol 144 6 (2005) 849-859
32. Small R. Systemic Pharmacology - Antihypertensive drugs. Anaesth Intensive Care Med 7 8 (2006) 298-302
33. Sharma J.N., and Abbas S.A. A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats. Pharmacol Res 52 3 (2005) 211-215
34. Persson K., Whiss P.A., Nyhlén K., Jacobsson-Strier M., Glindell M., and Andersson R.G.G. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-conversing enzyme activity and platelet aggregation in vitro. Eur J Pharmacol 406 (2000) 15-23
35. 2+ -stimulated ATPase activity. Anal Biochem 157 (1986) 375-380
36. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 218-254
37. Lineweaver H., and Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 56 (1934) 658-666
38. Dixon M., and Webb E.C. Enzyme Kinetics. 2nd. ed. (1964), Longman, London, U.K.
39. Ramamurthi A., Robson S.C., and Lewis R.S. Effects of nitric oxide (NO) and soluble nucleoside triphosphohydrolase (NTPDase) on inhibition of platelet deposition in vitro. Thromb Res 102 (2001) 331-341
40. Vasta V., Meacci E., Farnararo M., and Bruni P. Identification of a specific transport system for L-arginine in human platelets. Biochem Biophys Res Commun 206 3 (1995) 878-884
41. de Meireles L.R., Mendes-Ribeiro A.C., Santoro M.M., Mendes M.A., da Silva M.N., Mann G.E., et al. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in pletelet hyperaggregability in hypertension. Clinic Exp Pharmacol Physiol 34 12 (2007) 1267-1271
42. Batlouni M. Ativação plaquetária e trombose arterial. Arq Bras Cardiol 60 6 (1993) 425-431
43. Lages B., and Weiss H.J. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency-a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor. Thromb Haemost 77 2 (1997) 376-382
44. Sausbier M., Schubert R., Voigt V., Hirneiss C., Pfeifer A., Korth M., et al. Mechanisms of NO/cGMP-dependent vasorelaxation. Circ Res 87 (2000) 825
45. Ellershaw D.C., and Gurney A.M. Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery. Br J Pharmacol 134 (2001) 621-631
46. 2+-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil. Biochem Pharmacol 60 12 (2000) 1959-1965
47. Zurbano M.J., Anguera I., Heras M., Roig E., Lozano M., Sanz G., et al. Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIIa in early post myocardial infarction stage. Arterioscler Thromb Vasc Biol 19 1 (1999) 1791-1795
48. Someya N., Morotomi Y., Kodama K., Kida O., Higa T., Kondo K., et al. Suppressive effect of captopril on platelet aggregation in essential hypertension. J Cardiovasc Pharmacol 6 (1984) 840-843